News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Farwell Wildon
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/15/2023 |
4
| Farwell Wildon (Chief Medical Officer) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 7,441 shares
@ $13.33, valued at
$99.2k
|
|
| 12/13/2022 |
4
| Farwell Wildon (Chief Medical Officer) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 36,000 shares
@ $0
Sold 628 shares
@ $10.87, valued at
$6.8k
Granted 56,000 options to buy
@ $10.72, valued at
$600.3k
|
|
| 09/15/2022 |
4
| Farwell Wildon (Chief Medical Officer) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 658 shares
@ $14.05, valued at
$9.2k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|